dual IDO1/TDO inhibitors (IOmet/Merck & Co)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namedual IDO1/TDO inhibitors (IOmet/Merck & Co)

Drug Alias Namedual TDO/IDO inhibitors (IOmet Pharma)dual tryptophan dioxygenase/indolemaine 2,3-dioxygenase inhibitors (IOmet/Merck & Co)dual tryptophan dioxygenase/indolemaine 2,3-dioxygenase inhibitors (TPP Global Development)dual IDO checkpoint inhibitor/TDO checkpoint inhibitor (IOmet/Merck & Co)dual TDO/IDO inhibitors (TPP Global Development)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsTryptophan 2,3-dioxygenase inhibitors

TargetsTryptophan 2,3-dioxygenaseIndoleamine 2,3-dioxygenase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIomet Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIomet Pharma Ltd

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A